Marc Puigvehí

4PUBLICATIONS
42CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Regenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Feb 13, 2023
Identification of IGF2 as Genomic Driver and Actionable Therapeutic Target in Hepatoblastoma.

Jordi Abril-Fornaguera, Laura Torrens, Carmen Andreu-Oller

|Jun 22, 2021
Immunomodulatory Effects of Lenvatinib Plus Anti-Programmed Cell Death Protein 1 in Mice and Rationale for Patient Enrichment in Hepatocellular Carcinoma.

Laura Torrens, Carla Montironi, Marc Puigvehí

|Jun 13, 2019
β-Catenin Activation Promotes Immune Escape and Resistance to Anti-PD-1 Therapy in Hepatocellular Carcinoma.

Marina Ruiz de Galarreta, Erin Bresnahan, Pedro Molina-Sánchez

|Aug 31, 2018
Eight weeks of Paritaprevir/r/Ombitasvir + Dasabuvir in HCV genotype 1b with mild-moderate fibrosis: Results from a real-world cohort.

Marc Puigvehí, Beatriz De Cuenca, Ana Viu

Pageof 1

Frequent Collaborators

2 joint publications

Jordi Abril-Fornaguera

2 joint publications

Judit Peix

2 joint publications

Daniela Sia

2 joint publications

Josep M Llovet